Similarities and Differences of Vascular Calcification in Diabetes and Chronic Kidney Disease

References

• Demer LL. Effect of calcification on in vivo mechanical response of rabbit arteries to balloon dilation. Circulation. 1991;83(6):2083–2093. doi:10.1161/01.cir.83.6.2083
   PubMed Web of Science ®Google Scholar
• Proudfoot D, Shanahan CM. Biology of calcification in vascular cells: intima versus media. Herz. 2001;26(4):245–251. doi:10.1007/pl00002027
   PubMed Web of Science ®Google Scholar
• Rubin MR, Silverberg SJ. Vascular calcification and osteoporosis--The nature of the nexus. J Clin Endocrinol Metab. 2004;89(9):4243–4245. doi:10.1210/jc.2004-1324
   PubMed Web of Science ®Google Scholar
• Aghagolzadeh P, Bachtler M, Bijarnia R, et al. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α. Atherosclerosis. 2016;251:404–414. doi:10.1016/j.atherosclerosis.2016.05.044
   PubMed Web of Science ®Google Scholar
• Awan Z, Denis M, Roubtsova A, et al. Reducing vascular calcification by Anti-IL-1β monoclonal antibody in a mouse model of familial hypercholesterolemia. Angiology. 2016;67(2):157–167. doi:10.1177/0003319715583205
   PubMed Web of Science ®Google Scholar
• Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, Kumar A. Tumor necrosis factor-α regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS One. 2010;5(10):e13262. doi:10.1371/journal.pone.0013262
   PubMed Web of Science ®Google Scholar
• Hénaut L, Massy ZA. New insights into the key role of interleukin 6 in vascular calcification of chronic kidney disease. Nephrol Dial Transplant. 2018;33(4):543–548. doi:10.1093/ndt/gfx379
   PubMed Web of Science ®Google Scholar
• Byon CH, Javed A, Dai Q, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283(22):15319–15327. doi:10.1074/jbc.M800021200
   PubMed Web of Science ®Google Scholar
• Zhao MM, Xu MJ, Cai Y, et al. Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int. 2011;79(10):1071–1079. doi:10.1038/ki.2011.18
   PubMed Web of Science ®Google Scholar
• Kanno Y, Into T, Lowenstein CJ, Matsushita K. Nitric oxide regulates vascular calcification by interfering with TGF- signalling. Cardiovas Res. 2008;77(1):221–230. doi:10.1093/cvr/cvm049
   PubMed Web of Science ®Google Scholar
• Larivière R, Gauthier-Bastien A, Ung RV, et al. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease. J Hypert. 2017;35(2):376–384. doi:10.1097/hjh.0000000000001161
   PubMed Web of Science ®Google Scholar
• Sánchez-Duffhues G, García de Vinuesa A, van de Pol V, et al. Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2. J Pathol. 2019;247(3):333–346. doi:10.1002/path.5193
   PubMed Web of Science ®Google Scholar
• Archuleta TL, Lemieux AM, Saengsirisuwan V, et al. Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK. Free Radic Biol Med. 2009;47(10):1486–1493. doi:10.1016/j.freeradbiomed.2009.08.014
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271(5249):665–668. doi:10.1126/science.271.5249.665
   PubMed Web of Science ®Google Scholar
• Van Belle E, Rioufol G, Pouillot C, et al. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation. 2014;129(2):173–185. doi:10.1161/CIRCULATIONAHA.113.006646
   PubMed Web of Science ®Google Scholar
• You H, Yang H, Zhu Q, et al. Advanced oxidation protein products induce vascular calcification by promoting osteoblastic trans-differentiation of smooth muscle cells via oxidative stress and ERK pathway. Renal Failure. 2009;31(4):313–319. doi:10.1080/08860220902875182
   PubMed Web of Science ®Google Scholar
• Blanc A, Pandey NR, Srivastava AK. Distinct roles of Ca2+, calmodulin, and protein kinase C in H2O2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells. Antioxid Redox Signal. 2004;6(2):353–366. doi:10.1089/152308604322899422
   PubMed Web of Science ®Google Scholar
• Erickson JR, Joiner ML, Guan X, et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell. 2008;133(3):462–474. doi:10.1016/j.cell.2008.02.048
   PubMed Web of Science ®Google Scholar
• Liberman M, Bassi E, Martinatti MK, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;28(3):463–470. doi:10.1161/atvbaha.107.156745
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE. 2007;2007(407):cm8. doi:10.1126/stke.4072007cm8
   PubMedGoogle Scholar
• Feng H, Wang JY, Zheng M, et al. CTRP3 promotes energy production by inducing mitochondrial ROS and up-expression of PGC-1α in vascular smooth muscle cells. Exp Cell Res. 2016;341(2):177–186. doi:10.1016/j.yexcr.2016.02.001
   PubMed Web of Science ®Google Scholar
• Ribeiro S, Faria Mdo S, Silva G, et al. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene. Hemodial Int Symp Home Hemodial. 2012;16(4):481–490. doi:10.1111/j.1542-4758.2012.00687.x
   PubMed Web of Science ®Google Scholar
• Chu M, Wang AY, Chan IH, Chui SH, Lam CW. Serum small-dense LDL abnormalities in chronic renal disease patients. Br J Biomed Sci. 2012;69(3):99–102. doi:10.1080/09674845.2012.12069133
   PubMed Web of Science ®Google Scholar
• Bressendorff I, Hansen D, Schou M, et al. Oral magnesium supplementation in chronic kidney disease stages 3 and 4: efficacy, safety, and effect on serum calcification propensity-a prospective randomized double-blinded placebo-controlled clinical trial. Kidney Int Rep. 2017;2(3):380–389. doi:10.1016/j.ekir.2016.12.008
   PubMed Web of Science ®Google Scholar
• Montezano AC, Zimmerman D, Yusuf H, et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension. 2010;56(3):453–462. doi:10.1161/hypertensionaha.110.152058
   PubMed Web of Science ®Google Scholar
• de Oca A M, Guerrero F, Martinez-Moreno JM, et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One. 2014;9(2):e89525. doi:10.1371/journal.pone.0089525
   PubMed Web of Science ®Google Scholar
• Sonou T, Ohya M, Yashiro M, et al. Magnesium prevents phosphate-induced vascular calcification via TRPM7 and Pit-1 in an aortic tissue culture model. Hypertens Res. 2017;40(6):562–567. doi:10.1038/hr.2016.188
   PubMed Web of Science ®Google Scholar
• Louvet L, Metzinger L, Büchel J, Steppan S, Massy ZA. Magnesium attenuates phosphate-induced deregulation of a MicroRNA signature and prevents modulation of smad1 and osterix during the course of vascular calcification. Biomed Res Int. 2016;2016:7419524. doi:10.1155/2016/7419524
   PubMed Web of Science ®Google Scholar
• Nakatani S, Mori K, Shoji T, Emoto M. Association of zinc deficiency with development of CVD events in patients with CKD. Nutrients. 2021;13(5):1680. doi:10.3390/nu13051680
   PubMed Web of Science ®Google Scholar
• Hegazi RA, Sutton-Tyrrell K, Evans RW, et al. Relationship of adiposity to subclinical atherosclerosis in obese patients with type 2 diabetes. Obesity Res. 2003;11(12):1597–1605. doi:10.1038/oby.2003.212
   PubMedGoogle Scholar
• Nakanishi R, Rajani R, Cheng VY, et al. Increase in epicardial fat volume is associated with greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: a serial study using non-contrast cardiac CT. Atherosclerosis. 2011;218(2):363–368. doi:10.1016/j.atherosclerosis.2011.07.093
   PubMed Web of Science ®Google Scholar
• Daffu G, Del Pozo CH, O’Shea KM, Ananthakrishnan R, Ramasamy R, Schmidt AM. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci. 2013;14(10):19891–19910. doi:10.3390/ijms141019891
   PubMed Web of Science ®Google Scholar
• Hutchinson KR, Lord CK, West TA, Stewart JA Jr. Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes. PLoS One. 2013;8(8):e72080. doi:10.1371/journal.pone.0072080
   PubMed Web of Science ®Google Scholar
• Li JH, Huang XR, Zhu HJ, et al. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J. 2004;18(1):176–178. doi:10.1096/fj.02-1117fje
   PubMed Web of Science ®Google Scholar
• Liu RM, Gaston Pravia KA. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med. 2010;48(1):1–15. doi:10.1016/j.freeradbiomed.2009.09.026
   PubMed Web of Science ®Google Scholar
• Steitz SA, Speer MY, Curinga G, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001;89(12):1147–1154. doi:10.1161/hh2401.101070
   PubMed Web of Science ®Google Scholar
• Suga T, Iso T, Shimizu T, et al. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb. 2011;18(8):670–683. doi:10.5551/jat.7120
   PubMed Web of Science ®Google Scholar
• Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275(50):39027–39031. doi:10.1074/jbc.M006700200
   PubMed Web of Science ®Google Scholar
• Konova E, Baydanoff S, Atanasova M, Velkova A. Age-related changes in the glycation of human aortic elastin. Exp Gerontol. 2004;39(2):249–254. doi:10.1016/j.exger.2003.10.003
   PubMed Web of Science ®Google Scholar
• West SL, Swan VJ, Jamal SA. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population. Clin J Am Soc Nephrol. 2010;5 Suppl 1:S41–7. doi:10.2215/cjn.05860809
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao X, Shen Y, et al. MicroRNA-32 promotes calcification in vascular smooth muscle cells: implications as a novel marker for coronary artery calcification. PLoS One. 2017;12(3):e0174138. doi:10.1371/journal.pone.0174138
   PubMed Web of Science ®Google Scholar
• Lin L, He Y, Xi BL, et al. MiR-135a suppresses calcification in senescent VSMCs by regulating KLF4/STAT3 pathway. Curr Vasc Pharmacol. 2016;14(2):211–218. doi:10.2174/1570161113666150722151817
   PubMed Web of Science ®Google Scholar
• Song R, Fullerton DA, Ao L, Zhao KS, Meng X. An epigenetic regulatory loop controls pro-osteogenic activation by TGF-β1 or bone morphogenetic protein 2 in human aortic valve interstitial cells. J Biol Chem. 2017;292(21):8657–8666. doi:10.1074/jbc.M117.783308
   PubMed Web of Science ®Google Scholar
• Wu SS, Lin X, Yuan LQ, Liao EY. The role of epigenetics in arterial calcification. Biomed Res Int. 2015;2015:320849. doi:10.1155/2015/320849
   PubMed Web of Science ®Google Scholar
• Nanoudis S, Pikilidou M, Yavropoulou M, Zebekakis P. The Role of MicroRNAs in arterial stiffness and arterial calcification. an update and review of the literature. Front Genetics. 2017;8:209. doi:10.3389/fgene.2017.00209
   PubMed Web of Science ®Google Scholar
• Son DJ, Jung YY, Seo YS, et al. Interleukin-32alpha inhibits endothelial inflammation, vascular smooth muscle cell activation, and atherosclerosis by upregulating timp3 and reck through suppressing microRNA-205 biogenesis. Theranostics. 2017;7(8):2186–2203. doi:10.7150/thno.18407
   PubMed Web of Science ®Google Scholar
• Yao L, Chandra S, Toque HA, et al. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. Cardiovas Res. 2013;97(3):509–519. doi:10.1093/cvr/cvs371
   PubMed Web of Science ®Google Scholar
• Heath JM, Sun Y, Yuan K, et al. Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus. Circ Res. 2014;114(7):1094–1102. doi:10.1161/CIRCRESAHA.114.302968
   PubMed Web of Science ®Google Scholar
• Azpiazu D, Gonzalo S, Villa-Bellosta R. Tissue non-specific alkaline phosphatase and vascular calcification: a potential therapeutic target. Current Cardiol Rev. 2019;15(2):91–95. doi:10.2174/1573403x14666181031141226
   PubMed Web of Science ®Google Scholar
• Zickler D, Luecht C, Willy K, et al. Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expression. Nephrol Dial Transplant. 2018;33(4):574–585. doi:10.1093/ndt/gfx316
   PubMed Web of Science ®Google Scholar
• Pietrowski E, Bender B, Huppert J, White R, Luhmann HJ, Kuhlmann CRW. Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species. J Vascu Res. 2011;48(1):52–58. doi:10.1159/000317400
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, Estrela GR, Lechner SM, et al. The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling. Kidney Int. 2018;93(6):1344–1355. doi:10.1016/j.kint.2017.12.016
   PubMed Web of Science ®Google Scholar
• Canto C, Auwerx J. Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev. 2012;64(1):166–187. doi:10.1124/pr.110.003905
   PubMed Web of Science ®Google Scholar
• Liu X, Chen A, Liang Q, et al. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway. Aging Cell. 2021;20(6):e13377. doi:10.1111/acel.13377
   PubMed Web of Science ®Google Scholar
• Massy ZA, Ivanovski O, Nguyen-Khoa T, et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol. 2005;16(1):109–116. doi:10.1681/asn.2004060495
   PubMed Web of Science ®Google Scholar
• Sun H, Zhang F, Xu Y, et al. Salusin-β promotes vascular calcification via nicotinamide adenine dinucleotide phosphate/reactive oxygen species-mediated klotho downregulation. Antioxid Redox Signal. 2019;31(18):1352–1370. doi:10.1089/ars.2019.7723
   PubMed Web of Science ®Google Scholar
• Sutra T, Morena M, Bargnoux AS, Caporiccio B, Canaud B, Cristol JP. Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media. Free Radic Res. 2008;42(9):789–797. doi:10.1080/10715760802400766
   PubMed Web of Science ®Google Scholar
• Liu H, Li X, Qin F, Huang K. Selenium suppresses oxidative-stress-enhanced vascular smooth muscle cell calcification by inhibiting the activation of the PI3K/AKT and ERK signaling pathways and endoplasmic reticulum stress. J Bio Inorg Chem. 2014;19(3):375–388. doi:10.1007/s00775-013-1078-1
   PubMed Web of Science ®Google Scholar
• Gomez C, Martinez L, Mesa A, et al. Oxidative stress induces early-onset apoptosis of vascular smooth muscle cells and neointima formation in response to injury. Biosci Rep. 2015;35(4). doi:10.1042/bsr20140122
   PubMedGoogle Scholar
• Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014;307(8):F891–900. doi:10.1152/ajprenal.00163.2014
   PubMed Web of Science ®Google Scholar
• Erickson JR. Mechanisms of CaMKII activation in the heart. Front Pharmacol. 2014;5:59. doi:10.3389/fphar.2014.00059
   PubMed Web of Science ®Google Scholar
• Gutierrez DA, Fernandez-Tenorio M, Ogrodnik J, Niggli E. NO-dependent CaMKII activation during β-adrenergic stimulation of cardiac muscle. Cardiovas Res. 2013;100(3):392–401. doi:10.1093/cvr/cvt201
   PubMed Web of Science ®Google Scholar
• Meyer T, Hanson PI, Stryer L, Schulman H. Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science. 1992;256(5060):1199–1202. doi:10.1126/science.256.5060.1199
   PubMed Web of Science ®Google Scholar
• Erickson JR, Nichols CB, Uchinoumi H, Stein ML, Bossuyt J, Bers DM. S-Nitrosylation induces both autonomous activation and inhibition of calcium/calmodulin-dependent protein kinase II δ. J Biol Chem. 2015;290(42):25646–25656. doi:10.1074/jbc.M115.650234
   PubMed Web of Science ®Google Scholar
• Anderson ME. Oxidant stress promotes disease by activating CaMKII. J Mol Cell Cardiol. 2015;89(Pt B):160–167. doi:10.1016/j.yjmcc.2015.10.014
   PubMedGoogle Scholar
• Feng H, Wang JY, Yu B, et al. Peroxisome proliferator-activated receptor-γ coactivator-1α inhibits vascular calcification through sirtuin 3-mediated reduction of mitochondrial oxidative stress. Antioxid Redox Signal. 2019;31(1):75–91. doi:10.1089/ars.2018.7620
   PubMed Web of Science ®Google Scholar
• Jelic MD, Mandic AD, Maricic SM, Srdjenovic BU. Oxidative stress and its role in cancer. J Cancer Res Ther. 2021;17(1):22–28. doi:10.4103/jcrt.JCRT_862_16
   PubMed Web of Science ®Google Scholar
• Zheng L, Shen X, Ye J, Xie Y, Yan S. Metformin alleviates hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway. Life Sci. 2019;216:29–38. doi:10.1016/j.lfs.2018.11.008
   PubMed Web of Science ®Google Scholar
• Li T, Ni L, Liu X, Wang Z, Liu C. High glucose induces the expression of osteopontin in blood vessels in vitro and in vivo. Biochem Biophys Res Commun. 2016;480(2):201–207. doi:10.1016/j.bbrc.2016.10.027
   PubMed Web of Science ®Google Scholar
• Zhang X, Xiao J, Li R, et al. Metformin alleviates vascular calcification induced by vitamin D3 plus nicotine in rats via the AMPK pathway. Vascul Pharmacol. 2016;81:83–90. doi:10.1016/j.vph.2016.01.002
   PubMed Web of Science ®Google Scholar
• Byon CH, Heath JM, Chen Y. Redox signaling in cardiovascular pathophysiology: a focus on hydrogen peroxide and vascular smooth muscle cells. Redox Biol. 2016;9:244–253. doi:10.1016/j.redox.2016.08.015
   PubMed Web of Science ®Google Scholar
• Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5):1835. doi:10.3390/ijms21051835
   PubMed Web of Science ®Google Scholar
• Duvillard L, Florentin E, Pont F, et al. Endogenous chronic hyperinsulinemia does not increase the production rate of VLDL apolipoprotein B: proof from a kinetic study in patients with insulinoma. J Clin Endocrinol Metab. 2011;96(7):2163–2170. doi:10.1210/jc.2010-2946
   PubMed Web of Science ®Google Scholar
• Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci USA. 2004;101(44):15597–15602. doi:10.1073/pnas.0405238101
   PubMed Web of Science ®Google Scholar
• Chen NX, O’Neill K, Akl NK, Moe SM. Adipocyte induced arterial calcification is prevented with sodium thiosulfate. Biochem Biophys Res Commun. 2014;449(1):151–156. doi:10.1016/j.bbrc.2014.05.005
   PubMed Web of Science ®Google Scholar
• Yu B, Huo L, Liu Y, et al. PGC-1α controls skeletal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing TAZ. Cell Stem Cell. 2018;23(2):193–209.e5. doi:10.1016/j.stem.2018.06.009
   PubMed Web of Science ®Google Scholar
• Patten IS, Arany Z. PGC-1 coactivators in the cardiovascular system. Trend Endocrinol Metabol. 2012;23(2):90–97. doi:10.1016/j.tem.2011.09.007
   PubMed Web of Science ®Google Scholar
• Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A. Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol. 1987;65(4):729–745. doi:10.1139/y87-120
   PubMed Web of Science ®Google Scholar
• Ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep. 2018;8(1):2069. doi:10.1038/s41598-018-20241-3
   PubMedGoogle Scholar
• Miyata T, Sprague SM. Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis. Nephrol Dial Transplant. 1996;11 Suppl 3:86–90. doi:10.1093/ndt/11.supp3.86
   PubMed Web of Science ®Google Scholar
• Zimmerman CM, Padgett RW. Transforming growth factor β signaling mediators and modulators. Gene. 2000;249(1–2):17–30. doi:10.1016/s0378-1119(00)00162-1
   PubMed Web of Science ®Google Scholar
• Stefan N, Fritsche A, Weikert C, et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008;57(10):2762–2767. doi:10.2337/db08-0538
   PubMed Web of Science ®Google Scholar
• Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vascu Res. 2009;46(6):572–580. doi:10.1159/000226225
   PubMed Web of Science ®Google Scholar
• Hu Y, Chan E, Wang SX, Li B. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology. 2003;144(5):2068–2074. doi:10.1210/en.2002-220863
   PubMed Web of Science ®Google Scholar
• Janda K, Krzanowski M, Gajda M, et al. Vascular effects of advanced glycation end-products: content of immunohistochemically detected AGEs in radial artery samples as a predictor for arterial calcification and cardiovascular risk in asymptomatic patients with chronic kidney disease. Dis. Markers. 2015;2015:153978. doi:10.1155/2015/153978
   PubMed Web of Science ®Google Scholar
• Belmokhtar K, Ortillon J, Jaisson S, et al. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression. Nephrol Dial Transplant. 2019;34(12):2018–2030. doi:10.1093/ndt/gfz012
   PubMed Web of Science ®Google Scholar
• Cecil DL, Terkeltaub RA. Arterial calcification is driven by RAGE in Enpp1-/- mice. J Vascu Res. 2011;48(3):227–235. doi:10.1159/000318805
   PubMed Web of Science ®Google Scholar
• La Sala L, Micheloni S, De Nigris V, Prattichizzo F, Ceriello A. Novel insights into the regulation of miRNA transcriptional control: implications for T2D and related complications. Acta diabetologica. 2018;55(10):989–998. doi:10.1007/s00592-018-1149-4
   PubMed Web of Science ®Google Scholar
• Schorey JS, Cheng Y, Singh PP, Smith VL. Exosomes and other extracellular vesicles in host-pathogen interactions. EMBO Rep. 2015;16(1):24–43. doi:10.15252/embr.201439363
   PubMed Web of Science ®Google Scholar
• Deatherage BL, Cookson BT. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect Immun. 2012;80(6):1948–1957. doi:10.1128/iai.06014-11
   PubMed Web of Science ®Google Scholar
• Chaudhary SC, Khalid S, Smethurst V, et al. Proteomic profiling of extracellular vesicles released from vascular smooth muscle cells during initiation of phosphate-induced mineralization. Connect Tissue Res. 2018;53:55–61. doi:10.1080/03008207.2018.1444759
   Google Scholar
• Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000;87(11):1055–1062. doi:10.1161/01.res.87.11.1055
   PubMed Web of Science ®Google Scholar
• Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol. 1998;18(3):379–388. doi:10.1161/01.atv.18.3.379
   PubMed Web of Science ®Google Scholar
• Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15(11):2857–2867. doi:10.1097/01.Asn.0000141960.01035.28
   PubMed Web of Science ®Google Scholar
• Tuttle KR, Short RA. Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function. Clin J Am Soc Nephrol. 2009;4(12):1968–1973. doi:10.2215/cjn.01250209
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen J, Shen Z, et al. Indoxyl sulfate accelerates vascular smooth muscle cell calcification via microRNA-29b dependent regulation of Wnt/β-catenin signaling. Toxicol Lett. 2018;284:29–36. doi:10.1016/j.toxlet.2017.11.033
   PubMed Web of Science ®Google Scholar
• Alkagiet S, Tziomalos K. Vascular calcification: the role of microRNAs. Biomol Conc. 2017;8(2):119–123. doi:10.1515/bmc-2017-0001
   PubMedGoogle Scholar
• Badi I, Mancinelli L, Polizzotto A, et al. miR-34a promotes vascular smooth muscle cell calcification by downregulating SIRT1 (Sirtuin 1) and Axl (AXL Receptor Tyrosine Kinase). Arterioscler Thromb Vasc Biol. 2018;38(9):2079–2090. doi:10.1161/atvbaha.118.311298
   PubMed Web of Science ®Google Scholar
• Jiang W, Zhang Z, Yang H, Lin Q, Han C, Qin X. The Involvement of miR-29b-3p in arterial calcification by targeting matrix metalloproteinase-2. Biomed Res Int. 2017;2017:6713606. doi:10.1155/2017/6713606
   PubMed Web of Science ®Google Scholar
• Wen C, Yang X, Yan Z, et al. Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification. Int J Cardiol. 2013;168(3):2242–2247. doi:10.1016/j.ijcard.2013.01.211
   PubMed Web of Science ®Google Scholar
• Duan X, Zhou Y, Teng X, Tang C, Qi Y. Endoplasmic reticulum stress-mediated apoptosis is activated in vascular calcification. Biochem Biophys Res Commun. 2009;387(4):694–699. doi:10.1016/j.bbrc.2009.07.085
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang KC, Wu W, et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci USA. 2011;108(25):10355–10360. doi:10.1073/pnas.1107052108
   PubMed Web of Science ®Google Scholar
• Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103(33):12481–12486. doi:10.1073/pnas.0605298103
   PubMed Web of Science ®Google Scholar
• Hou J, Wang P, Lin L, et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol. 2009;183(3):2150–2158. doi:10.4049/jimmunol.0900707
   PubMed Web of Science ®Google Scholar
• Leopold JA. MicroRNAs Regulate Vascular Medial Calcification. Cells. 2014;3(4):963–980. doi:10.3390/cells3040963
   PubMedGoogle Scholar
• Dusing P, Zietzer A, Goody PR, et al. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J Mol Med. 2021;99(3):335–348. doi:10.1007/s00109-021-02037-7
   PubMed Web of Science ®Google Scholar
• Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436–2443. doi:10.1093/eurheartj/eht149
   PubMed Web of Science ®Google Scholar
• Yamagishi S. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol. 2011;46(4):217–224. doi:10.1016/j.exger.2010.11.007
   PubMed Web of Science ®Google Scholar
• Luong TTD, Schelski N, Boehme B, et al. Fibulin-3 attenuates phosphate-induced vascular smooth muscle cell calcification by inhibition of oxidative stress. Cell Physiol Biochem. 2018;46(4):1305–1316. doi:10.1159/000489144
   PubMedGoogle Scholar
• Yang K, Nie L, Huang Y, et al. Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein. Toxicol Lett. 2012;215(2):77–83. doi:10.1016/j.toxlet.2012.10.004
   PubMed Web of Science ®Google Scholar
• Chavkin NW, Chia JJ, Crouthamel MH, Giachelli CM. Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells. Exp Cell Res. 2015;333(1):39–48. doi:10.1016/j.yexcr.2015.02.002
   PubMed Web of Science ®Google Scholar
• Yamada S, Leaf EM, Chia JJ, Cox TC, Speer MY, Giachelli CM. PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet. Kidney Int. 2018;94(4):716–727. doi:10.1016/j.kint.2018.05.015
   PubMed Web of Science ®Google Scholar
• Voelkl J, Tuffaha R, Luong TTD, et al. Zinc Inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-κB. J Am Soc Nephrol. 2018;29(6):1636–1648. doi:10.1681/asn.2017050492
   PubMed Web of Science ®Google Scholar
• Ding H, Li D, Zhang Y, et al. Luteolin inhibits smooth muscle cell migration and proliferation by attenuating the production of Nox4, p-Akt and VEGF in endothelial cells. Current Pharm Biotechnol. 2014;14(12):1009–1015. doi:10.2174/1389201015666140113113843
   PubMed Web of Science ®Google Scholar
• Speer T, Owala FO, Holy EW, et al. Carbamylated low-density lipoprotein induces endothelial dysfunction. Eur Heart J. 2014;35(43):3021–3032. doi:10.1093/eurheartj/ehu111
   PubMed Web of Science ®Google Scholar
• Wasty F, Alavi MZ, Moore S. Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia. 1993;36(4):316–322. doi:10.1007/bf00400234
   PubMed Web of Science ®Google Scholar
• Sowers KM, Hayden MR. Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches. Oxid Med Cell Longev. 2010;3(2):109–121. doi:10.4161/oxim.3.2.11354
   PubMed Web of Science ®Google Scholar
• Young KA, Snell-Bergeon JK, Naik RG, et al. Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care. 2011;34(2):454–458. doi:10.2337/dc10-0757
   PubMed Web of Science ®Google Scholar
• Azechi T, Sato F, Sudo R, Wachi H. 5-aza-2’-Deoxycytidine, a DNA methyltransferase inhibitor, facilitates the inorganic phosphorus-induced mineralization of vascular smooth muscle cells. J Atheroscler Thromb. 2014;21(5):463–476. doi:10.5551/jat.20818
   PubMed Web of Science ®Google Scholar
• Villa JKD, Diaz MAN, Pizziolo VR, Martino HSD. Effect of vitamin K in bone metabolism and vascular calcification: a review of mechanisms of action and evidences. Crit Rev Food Sci Nutr. 2017;57(18):3959–3970. doi:10.1080/10408398.2016.1211616
   PubMed Web of Science ®Google Scholar
• Liu Q, Qi H, Yao L. A long non-coding RNA H19/microRNA-138/TLR3 network is involved in high phosphorus-mediated vascular calcification and chronic kidney disease. Cell Cycle. 2022;21(16):1667–1683. doi:10.1080/15384101.2022.2064957
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen J, Meng Q, et al. The protective effects of long non-coding RNA-ANCR on arterial calcification. J Bone Mineral Metabol. 2020;38(4):421–431. doi:10.1007/s00774-019-01076-y
   PubMed Web of Science ®Google Scholar
• Wang D, Deuse T, Stubbendorff M, et al. Local MicroRNA modulation using a novel anti-mir-21-eluting stent effectively prevents experimental in-stent restenosis. Arterioscler Thromb Vasc Biol. 2015;35(9):1945–1953. doi:10.1161/atvbaha.115.305597
   PubMed Web of Science ®Google Scholar
• Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS. Role of the gut microbiome in uremia: a potential therapeutic target. Am J Kidney Dis. 2016;67(3):483–498. doi:10.1053/j.ajkd.2015.09.027
   PubMed Web of Science ®Google Scholar
• Ahmad MS, Krishnan S, Ramakrishna BS, Mathan M, Pulimood AB, Murthy SN. Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut. 2000;46(4):493–499. doi:10.1136/gut.46.4.493
   PubMed Web of Science ®Google Scholar
• Felici C, Ciari I, Terzuoli L, et al. Purine catabolism in advanced carotid artery plaque. Nucleosides Nucleotides Nucleic Acids. 2006;25(9–11):1291–1294. doi:10.1080/15257770600890772
   PubMed Web of Science ®Google Scholar
• Cheng ZY, Ye T, Ling QY, Wu T, Wu GY, Zong GJ. Parathyroid hormone promotes osteoblastic differentiation of endothelial cells via the extracellular signal-regulated protein kinase 1/2 and nuclear factor-κB signaling pathways. Exp Ther Med. 2018;15(2):1754–1760. doi:10.3892/etm.2017.5545
   PubMed Web of Science ®Google Scholar
• Yao H, Sun Z, Zang G, et al. Epidemiological research advances in vascular calcification in diabetes. J Diabetes Res. 2021;2021:4461311. doi:10.1155/2021/4461311
   PubMed Web of Science ®Google Scholar
• Walrand S, Guillet C, Boirie Y, Vasson MP. In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukocy Biol. 2004;76(6):1104–1110. doi:10.1189/jlb.0104050
   PubMed Web of Science ®Google Scholar
• Jaffe IZ, Tintut Y, Newfell BG, Demer LL, Mendelsohn ME. Mineralocorticoid receptor activation promotes vascular cell calcification. Arteriosclerosis Thrombosis Vasc Biol. 2007;27(4):799–805. doi:10.1161/01.ATV.0000258414.59393.89
   PubMed Web of Science ®Google Scholar
• de Seigneux S, Martin PY. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition. Pharmacol Res. 2016;106:87–91. doi:10.1016/j.phrs.2016.02.015
   PubMed Web of Science ®Google Scholar
• Kolkhof P, Lawatscheck R, Filippatos G, Bakris GL. Nonsteroidal mineralocorticoid receptor antagonism by finerenone-translational aspects and clinical perspectives across multiple organ systems. Int J Mol Sci. 2022;23(16):9243. doi:10.3390/ijms23169243
   PubMed Web of Science ®Google Scholar
• Kawakami R, Katsuki S, Travers R, et al. S100A9-RAGE axis accelerates formation of macrophage-mediated extracellular vesicle microcalcification in diabetes mellitus. Arterioscler Thromb Vasc Biol. 2020;40(8):1838–1853. doi:10.1161/atvbaha.118.314087
   PubMed Web of Science ®Google Scholar
• Agharazii M, St-Louis R, Gautier-Bastien A, et al. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Am J Hypertens. 2015;28(6):746–755. doi:10.1093/ajh/hpu225
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Quan X, Xu S, et al. Intracellular alkalinization by phosphate uptake via type III sodium-phosphate cotransporter participates in high-phosphate-induced mitochondrial oxidative stress and defective insulin secretion. FASEB J. 2016;30(12):3979–3988. doi:10.1096/fj.201600455RR
   PubMed Web of Science ®Google Scholar
• Al-Qaridhi A, Ghosh S, Luo D, Huang H. Magnesium and zinc intake ratio mediates the increase of coronary artery calcification through upregulating interleukin 6. Libyan J Med. 2022;17(1):2028997. doi:10.1080/19932820.2022.2028997
   PubMed Web of Science ®Google Scholar
• Viegas C, Araújo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging. 2019;11(12):4274–4299. doi:10.18632/aging.102046
   PubMedGoogle Scholar
• Kuro OM. The Klotho proteins in health and disease. Nat Rev Nephrol. 2019;15(1):27–44. doi:10.1038/s41581-018-0078-3
   PubMed Web of Science ®Google Scholar
• Ivanovski O, Nikolov IG, Joki N, et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis. 2009;205(1):55–62. doi:10.1016/j.atherosclerosis.2008.10.043
   PubMed Web of Science ®Google Scholar
• Kawata T, Nagano N, Obi M, et al. Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney Int. 2008;74(10):1270–1277. doi:10.1038/ki.2008.407
   PubMed Web of Science ®Google Scholar
• Hilfiker H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA. 1998;95(24):14564–14569. doi:10.1073/pnas.95.24.14564
   PubMed Web of Science ®Google Scholar
• Segawa H, Kaneko I, Takahashi A, et al. Growth-related renal type II Na/Pi cotransporter. J Biol Chem. 2002;277(22):19665–19672. doi:10.1074/jbc.M200943200
   PubMed Web of Science ®Google Scholar
• Tatsumi S, Miyagawa A, Kaneko I, Shiozaki Y, Segawa H, Miyamoto K. Regulation of renal phosphate handling: inter-organ communication in health and disease. J Bone Mineral Metabol. 2016;34(1):1–10. doi:10.1007/s00774-015-0705-z
   PubMed Web of Science ®Google Scholar
• Hernando N, Gagnon K, Lederer E. Phosphate Transport in Epithelial and Nonepithelial Tissue. Physiol Rev. 2021;101(1):1–35. doi:10.1152/physrev.00008.2019
   PubMed Web of Science ®Google Scholar
• Forster IC, Hernando N, Biber J, Murer H. Phosphate transporters of the SLC20 and SLC34 families. Mol Aspect Med. 2013;34(2–3):386–395. doi:10.1016/j.mam.2012.07.007
   PubMed Web of Science ®Google Scholar
• Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res. 2006;98(7):905–912. doi:10.1161/01.RES.0000216409.20863.e7
   PubMed Web of Science ®Google Scholar
• Zhao G, Xu MJ, Zhao MM, et al. Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression. Kidney Int. 2012;82(1):34–44. doi:10.1038/ki.2012.40
   PubMed Web of Science ®Google Scholar
• Yoshida T, Yamashita M, Horimai C, Hayashi M. Smooth muscle-selective nuclear factor-κB inhibition reduces phosphate-induced arterial medial calcification in mice with chronic kidney disease. J Am Heart Assoc. 2017;6(11). doi:10.1161/jaha.117.007248
   Web of Science ®Google Scholar
• Lee HL, Woo KM, Ryoo HM, Baek JH. Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun. 2010;391(1):1087–1092. doi:10.1016/j.bbrc.2009.12.027
   PubMed Web of Science ®Google Scholar
• Panizo S, Cardus A, Encinas M, et al. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res. 2009;104(9):1041–1048. doi:10.1161/circresaha.108.189001
   PubMed Web of Science ®Google Scholar
• Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Invest Drugs. 2013;22(6):701–714. doi:10.1517/13543784.2013.778971
   PubMed Web of Science ®Google Scholar
• Voelkl J, Luong TT, Tuffaha R, et al. SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling. J Clin Invest. 2018;128(7):3024–3040. doi:10.1172/jci96477
   PubMed Web of Science ®Google Scholar
• Schelski N, Luong TTD, Lang F, Pieske B, Voelkl J, Alesutan I. SGK1-dependent stimulation of vascular smooth muscle cell osteo-/chondrogenic transdifferentiation by interleukin-18. Pflugers Archiv. 2019;471(6):889–899. doi:10.1007/s00424-019-02256-5
   PubMed Web of Science ®Google Scholar
• Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest. 2005;115(5):1210–1220. doi:10.1172/jci24140
   PubMed Web of Science ®Google Scholar
• Yao L, Sun YT, Sun W, et al. High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease. Am J Nephrol. 2015;41(1):28–36. doi:10.1159/000370250
   PubMed Web of Science ®Google Scholar
• Cai T, Sun D, Duan Y, et al. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res. 2016;345(2):206–217. doi:10.1016/j.yexcr.2016.06.007
   PubMed Web of Science ®Google Scholar
• Freise C, Kretzschmar N, Querfeld U. Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases. BMC Cardiovascu Disord. 2016;16(1):185. doi:10.1186/s12872-016-0362-8
   PubMedGoogle Scholar
• Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 2003;18(10):1842–1853. doi:10.1359/jbmr.2003.18.10.1842
   PubMed Web of Science ®Google Scholar
• Lim K, T-S L, Molostvov G, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation. 2012;125(18):2243–2255. doi:10.1161/CIRCULATIONAHA.111.053405
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao MM, Cai Y, et al. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation. Kidney Int. 2015;88(4):711–721. doi:10.1038/ki.2015.160
   PubMed Web of Science ®Google Scholar
• Jewell JL, Guan KL. Nutrient signaling to mTOR and cell growth. Trends Biochem Sci. 2013;38(5):233–242. doi:10.1016/j.tibs.2013.01.004
   PubMed Web of Science ®Google Scholar
• Vervloet MG, Adema AY, Larsson TE, Massy ZA. The role of klotho on vascular calcification and endothelial function in chronic kidney disease. Semin Nephrol. 2014;34(6):578–585. doi:10.1016/j.semnephrol.2014.09.003
   PubMed Web of Science ®Google Scholar
• Martinet W, De Loof H, De Meyer GRY. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques. Atherosclerosis. 2014;233(2):601–607. doi:10.1016/j.atherosclerosis.2014.01.040
   PubMed Web of Science ®Google Scholar
• Elloso MM, Azrolan N, Sehgal SN, et al. Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice. Am J Transplant. 2003;3(5):562–569. doi:10.1034/j.1600-6143.2003.00094.x
   PubMed Web of Science ®Google Scholar
• Liberman M, Johnson RC, Handy DE, Loscalzo J, Leopold JA. Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys Res Commun. 2011;413(3):436–441. doi:10.1016/j.bbrc.2011.08.114
   PubMed Web of Science ®Google Scholar
• Zhang D, Bi X, Liu Y, et al. High phosphate-induced calcification of vascular smooth muscle cells is associated with the TLR4/NF-κb signaling pathway. Kidney Blood Press Res. 2017;42(6):1205–1215. doi:10.1159/000485874
   PubMed Web of Science ®Google Scholar
• Sage AP, Lu J, Tintut Y, Demer LL. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int. 2011;79(4):414–422. doi:10.1038/ki.2010.390
   PubMed Web of Science ®Google Scholar
• Leibrock CB, Alesutan I, Voelkl J, et al. NH4Cl treatment prevents tissue calcification in klotho deficiency. J Am Soc Nephrol. 2015;26(10):2423–2433. doi:10.1681/asn.2014030230
   PubMed Web of Science ®Google Scholar
• Alesutan I, Musculus K, Castor T, Alzoubi K, Voelkl J, Lang F. Inhibition of phosphate-induced vascular smooth muscle cell osteo-/chondrogenic signaling and calcification by bafilomycin A1 and methylamine. Kidney Blood Press Res. 2015;40(5):490–499. doi:10.1159/000368524
   PubMed Web of Science ®Google Scholar
• Abbasian N, Burton JO, Herbert KE, et al. Hyperphosphatemia, phosphoprotein phosphatases, and microparticle release in vascular endothelial cells. J Am Soc Nephrol. 2015;26(9):2152–2162. doi:10.1681/asn.2014070642
   PubMed Web of Science ®Google Scholar
• Soriano S, Carmona A, Triviño F, et al. Endothelial damage and vascular calcification in patients with chronic kidney disease. Am J Physiol Renal Physiol. 2014;307(11):F1302–F1311. doi:10.1152/ajprenal.00114.2014
   PubMed Web of Science ®Google Scholar
• Alique M, Bodega G, Corchete E, et al. Microvesicles from indoxyl sulfate-treated endothelial cells induce vascular calcification in vitro. Comput Struct Biotechnol J. 2020;18:953–966. doi:10.1016/j.csbj.2020.04.006
   PubMed Web of Science ®Google Scholar
• Sulistyowati E, Permatasari N, Aris Widodo M. Combined effects of shear stress and glucose on the morphology, actin filaments, and VE-cadherin of endothelial cells in vitro. Int J Cardiol Heart Vasculature. 2017;15:31–35. doi:10.1016/j.ijcha.2017.03.004
   PubMedGoogle Scholar
• Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W. Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol. 2016;13(7):404–417. doi:10.1038/nrcardio.2016.73
   PubMed Web of Science ®Google Scholar
• Cianciolo G, La Manna G, Della Bella E, et al. Effect of vitamin D receptor activator therapy on vitamin D receptor and osteocalcin expression in circulating endothelial progenitor cells of hemodialysis patients. Blood Purif. 2013;35(1–3):187–195. doi:10.1159/000347102
   PubMed Web of Science ®Google Scholar
• Jiang YJ, Teichert AE, Fong F, Oda Y, Bikle DD. 1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway. J Steroid Biochem Mol Biol. 2013;136:229–232. doi:10.1016/j.jsbmb.2012.09.024
   PubMed Web of Science ®Google Scholar
• Prié D, Friedlander G. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Clin J Am Soc Nephrol. 2010;5(9):1717–1722. doi:10.2215/CJN.02680310
   PubMed Web of Science ®Google Scholar
• Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant. 2006;21(4):889–897. doi:10.1093/ndt/gfi254
   PubMed Web of Science ®Google Scholar
• Vissers LET, Dalmeijer GW, Boer JMA, Verschuren WMM, van der Schouw YT, Beulens JWJ. The relationship between vitamin K and peripheral arterial disease. Atherosclerosis. 2016;252:15–20. doi:10.1016/j.atherosclerosis.2016.07.915
   PubMed Web of Science ®Google Scholar
• Xie SA, Zhang T, Wang J, et al. Matrix stiffness determines the phenotype of vascular smooth muscle cell in vitro and in vivo: role of DNA methyltransferase 1. Biomaterials. 2018;155:203–216. doi:10.1016/j.biomaterials.2017.11.033
   PubMed Web of Science ®Google Scholar
• Kétszeri M, Kirsch A, Frauscher B, et al. MicroRNA-142-3p improves vascular relaxation in uremia. Atherosclerosis. 2019;280:28–36. doi:10.1016/j.atherosclerosis.2018.11.024
   PubMed Web of Science ®Google Scholar
• Zhan Q, Song R, Zeng Q, et al. Activation of TLR3 induces osteogenic responses in human aortic valve interstitial cells through the NF-κB and ERK1/2 pathways. Int J Bio Sci. 2015;11(4):482–493. doi:10.7150/ijbs.10905
   Google Scholar
• Mahmoodpoor F, Rahbar Saadat Y, Barzegari A, Ardalan M, Zununi Vahed S. The impact of gut microbiota on kidney function and pathogenesis. Biomed Pharmacother. 2017;93:412–419. doi:10.1016/j.biopha.2017.06.066
   PubMed Web of Science ®Google Scholar
• Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci. 2019;21(1):263. doi:10.3390/ijms21010263
   PubMed Web of Science ®Google Scholar
• Pieniazek A, Bernasinska-Slomczewska J, Gwozdzinski L. Uremic toxins and their relation with oxidative stress induced in patients with CKD. Int J Mol Sci. 2021;22(12):6196. doi:10.3390/ijms22126196
   PubMed Web of Science ®Google Scholar
• Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol. 1995;15(10):1616–1624. doi:10.1161/01.atv.15.10.1616
   PubMed Web of Science ®Google Scholar
• Patetsios P, Song M, Shutze WP, et al. Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol. 2001;88(2):188–91, a6. doi:10.1016/s0002-9149(01)01621-6
   PubMed Web of Science ®Google Scholar
• Armstrong ZB, Boughner DR, Drangova M, Rogers KA. Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovas Res. 2011;90(1):165–170. doi:10.1093/cvr/cvq391
   PubMed Web of Science ®Google Scholar
• Alesutan I, Voelkl J, Feger M, et al. Involvement of vascular aldosterone synthase in phosphate-induced osteogenic transformation of vascular smooth muscle cells. Sci Rep. 2017;7(1):2059. doi:10.1038/s41598-017-01882-2
   PubMedGoogle Scholar
• Lang F, Ritz E, Voelkl J, Alesutan I. Vascular calcification--is aldosterone a culprit? Nephrol Dial Transplant. 2013;28(5):1080–1084. doi:10.1093/ndt/gft041
   PubMed Web of Science ®Google Scholar
• Mori K, Shioi A, Jono S, Nishizawa Y, Morii H. Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19(9):2112–2118. doi:10.1161/01.atv.19.9.2112
   PubMed Web of Science ®Google Scholar
• Cohn-Schwartz D, Schary Y, Yalon E, et al. PTH-induced bone regeneration and vascular modulation are both dependent on endothelial signaling. Cells. 2022;11(5):897. doi:10.3390/cells11050897
   PubMed Web of Science ®Google Scholar
• Iguchi T, Hasegawa T, Otsuka K, et al. Insulin resistance is associated with coronary plaque vulnerability: insight from optical coherence tomography analysis. Europ Heart J Cardiovas Imag. 2014;15(3):284–291. doi:10.1093/ehjci/jet158
   PubMed Web of Science ®Google Scholar
• Verma A, Vaidya A, Subudhi S, Waikar SS. Aldosterone in chronic kidney disease and renal outcomes. Eur Heart J. 2022;43(38):3781–3791. doi:10.1093/eurheartj/ehac352
   PubMed Web of Science ®Google Scholar
• Neven E, Vervaet B, Brand K, et al. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder. Kidney Int. 2018;94(1):102–113. doi:10.1016/j.kint.2018.01.027
   PubMed Web of Science ®Google Scholar
• Cao X, Li H, Tao H, et al. Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology. 2013;154(10):3680–3689. doi:10.1210/en.2013-1002
   PubMed Web of Science ®Google Scholar
• Mohammed I, Hollenberg MD, Ding H, Triggle CR. A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan. Front Endocrinol. 2021;12:718942. doi:10.3389/fendo.2021.718942
   PubMed Web of Science ®Google Scholar
• Scirpo R, Fiorotto R, Villani A, Amenduni M, Spirli C, Strazzabosco M. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology. 2015;62(5):1551–1562. doi:10.1002/hep.28000
   PubMed Web of Science ®Google Scholar
• Martens FMAC, Rabelink TJ, op ‘t Roodt J, de Koning EJP, Visseren FLJ. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone. Eur Heart J. 2006;27(13):1605–1609. doi:10.1093/eurheartj/ehl079
   PubMed Web of Science ®Google Scholar
• Li J, Shen X. Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Diabetol Metab Syndr. 2019;11:35. doi:10.1186/s13098-019-0432-z
   PubMed Web of Science ®Google Scholar
• Diwan V, Gobe G, Brown L. Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease. Pharmacol Res. 2014;79:104–110. doi:10.1016/j.phrs.2013.11.007
   PubMed Web of Science ®Google Scholar
• Mirza RE, Fang MM, Weinheimer-Haus EM, Ennis WJ, Koh TJ. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes. 2014;63(3):1103–1114. doi:10.2337/db13-0927
   PubMed Web of Science ®Google Scholar
• Schinzari F, Tesauro M, Bertoli A, et al. Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents. Am J Physiol Endocrinol Metab. 2019;317(4):E658–E666. doi:10.1152/ajpendo.00204.2019
   PubMed Web of Science ®Google Scholar
• Dowling JK, O’Neill LA. Biochemical regulation of the inflammasome. Crit Rev Biochem Mol Biol. 2012;47(5):424–443. doi:10.3109/10409238.2012.694844
   PubMed Web of Science ®Google Scholar
• Ott C, Kistner I, Keller M, et al. Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial. Diabetologia. 2016;59(12):2579–2587. doi:10.1007/s00125-016-4083-4
   PubMed Web of Science ®Google Scholar
• Busek P, Duke-Cohan JS, Sedo A. Does DPP-IV inhibition offer new avenues for therapeutic intervention in malignant disease? Cancers. 2022;14(9). doi:10.3390/cancers14092072
   PubMed Web of Science ®Google Scholar
• Bosch A, Ott C, Jung S, et al. How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial. Cardiov Diabetol. 2019;18(1):44. doi:10.1186/s12933-019-0839-8
   PubMedGoogle Scholar
• Zhan J-K, Tan P, Wang Y-J, et al. Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway. Cardiov Diabetol. 2014;13:153. doi:10.1186/s12933-014-0153-4
   PubMed Web of Science ®Google Scholar
• Lin Y-C, Chen Y-C, Hsiao H-P, et al. The effects of acarbose on chemokine and cytokine production in human monocytic THP-1 cells. Hormones. 2019;18(2):179–187. doi:10.1007/s42000-019-00101-z
   PubMedGoogle Scholar
• Mo D, Liu S, Ma H, et al. Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study. Drug Des Devel Ther. 2019;13:2769–2776. doi:10.2147/DDDT.S208327
   PubMed Web of Science ®Google Scholar
• Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med. 2021;171(2):179–189. doi:10.1007/s10517-021-05191-7
   PubMed Web of Science ®Google Scholar
• Rafael MS, Cavaco S, Viegas CSB, et al. Insights into the association of Gla-rich protein and osteoarthritis, novel splice variants and γ-carboxylation status. Mol Nutr Food Res. 2014;58(8):1636–1646. doi:10.1002/mnfr.201300941
   PubMed Web of Science ®Google Scholar
• Stock M, Menges S, Eitzinger N, et al. A dual role of upper zone of growth plate and cartilage matrix-associated protein in human and mouse osteoarthritic cartilage: inhibition of aggrecanases and promotion of bone turnover. Arthritis Rheumatol. 2017;69(6):1233–1245. doi:10.1002/art.40042
   PubMed Web of Science ®Google Scholar
• Lattenist L, Lechner SM, Messaoudi S, et al. Nonsteroidal mineralocorticoid receptor antagonist finerenone protects against acute kidney injury-mediated chronic kidney disease: role of oxidative stress. Hypertension. 2017;69(5):870–878. doi:10.1161/HYPERTENSIONAHA.116.08526
   PubMed Web of Science ®Google Scholar
• Gil-Ortega M, Vega-Martín E, Martín-Ramos M, et al. Finerenone reduces intrinsic arterial stiffness in Munich Wistar frömter rats, a genetic model of chronic kidney disease. Am J Nephrol. 2020;51(4):294–303. doi:10.1159/000506275
   PubMed Web of Science ®Google Scholar
• Luther JM, Gainer JV, Murphey LJ, et al. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension. 2006;48(6):1050–1057. doi:10.1161/01.HYP.0000248135.97380.76
   PubMed Web of Science ®Google Scholar
• Sirtori CR. The pharmacology of statins. Pharmacol Res. 2014;88:3–11. doi:10.1016/j.phrs.2014.03.002
   PubMed Web of Science ®Google Scholar
• Cheng S, Coyne D. Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease. Therap Clin Risk Manag. 2006;2(3):297–301. doi:10.2147/tcrm.2006.2.3.297
   PubMedGoogle Scholar
• Strauss HW, Nakahara T, Narula N, Narula J. Vascular calcification: the evolving relationship of vascular calcification to major acute coronary events. J Nucl Med. 2019;60(9):1207–1212. doi:10.2967/jnumed.119.230276
   PubMed Web of Science ®Google Scholar
• Shea MK, Holden RM. Vitamin K status and vascular calcification: evidence from observational and clinical studies. Advan Nutr. 2012;3(2):158–165. doi:10.3945/an.111.001644
   PubMed Web of Science ®Google Scholar
• Tsimikas S. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol. 2017;69(6):692–711. doi:10.1016/j.jacc.2016.11.042
   PubMed Web of Science ®Google Scholar
• Lee SE, Chang HJ, Sung JM, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. JACC Cardiovasc Imaging. 2018;11(10):1475–1484. doi:10.1016/j.jcmg.2018.04.015
   PubMed Web of Science ®Google Scholar
• Handelsman Y, Lepor NE. PCSK9 inhibitors in lipid management of patients with diabetes mellitus and high cardiovascular risk: a review. J Am Heart Assoc. 2018;7(13). doi:10.1161/JAHA.118.008953
   PubMed Web of Science ®Google Scholar
• Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20(6):953–966. doi:10.1016/j.cmet.2014.09.018
   PubMed Web of Science ®Google Scholar
• Feng X, Chen W, Ni X, et al. Metformin, macrophage dysfunction and atherosclerosis. Front Immunol. 2021;12:682853. doi:10.3389/fimmu.2021.682853
   PubMed Web of Science ®Google Scholar
• Reinhold S, Blankesteijn WM, Foulquier S. The Interplay of WNT and PPARγ signaling in vascular calcification. Cells. 2020;9(12):2658. doi:10.3390/cells9122658
   PubMed Web of Science ®Google Scholar
• Chen YH, Chiang MH, Liu JS, et al. Thiazolidinediones and risk of long-term dialysis in diabetic patients with advanced chronic kidney disease: a nationwide cohort study. PLoS One. 2015;10(6):e0129922. doi:10.1371/journal.pone.0129922
   PubMed Web of Science ®Google Scholar
• Usuda R. スルホニル尿素 [Sulfonylurea]. Nihon Rinsho. 2015;73(3):409–415. Japanese.
   PubMedGoogle Scholar
• Barchetta I, Ciccarelli G, Barone E, et al. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2019;29(10):1087–1094. doi:10.1016/j.numecd.2019.07.010
   PubMed Web of Science ®Google Scholar
• He J, Yuan G, Cheng F, Zhang J, Guo X. Mast cell and M1 macrophage infiltration and local pro-inflammatory factors were attenuated with incretin-based therapies in obesity-related glomerulopathy. Metab Syndr Relat Disord. 2017;15(7):344–353. doi:10.1089/met.2017.0057
   PubMed Web of Science ®Google Scholar
• Swerdlow AJ, Laing SP, Qiao Z, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer. 2005;92(11):2070–2075. doi:10.1038/sj.bjc.6602611
   PubMed Web of Science ®Google Scholar
• Loutradis C, Papadopoulou E, Angeloudi E, Karagiannis A, Sarafidis P. The beneficial hemodynamic actions of SGLT-2 inhibitors beyond the management of hyperglycemia. Curr Med Chem. 2020;27(39):6682–6702. doi:10.2174/0929867326666191029111713
   PubMed Web of Science ®Google Scholar
• Han JH, Oh TJ, Lee G, et al. The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE (-/-) mice fed a western diet. Diabetologia. 2017;60(2):364–376. doi:10.1007/s00125-016-4158-2
   PubMed Web of Science ®Google Scholar
• Levin A, Perkovic V, Wheeler DC, et al. Empagliflozin and cardiovascular and kidney outcomes across KDIGO risk categories: post hoc analysis of a randomized, double-blind, placebo-controlled, multinational trial. Clin J Am Soc Nephrol. 2020;15(10):1433–1444. doi:10.2215/CJN.14901219
   PubMed Web of Science ®Google Scholar
• Giugliano D, Longo M, Scappaticcio L, Bellastella G, Maiorino MI, Esposito K. SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs. Cardiovasc Diabetol. 2021;20(1):236. doi:10.1186/s12933-021-01430-3
   PubMed Web of Science ®Google Scholar
• Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740–756. doi:10.1016/j.cmet.2018.03.001
   PubMed Web of Science ®Google Scholar
• Helmstädter J, Keppeler K, Küster L, Münzel T, Daiber A, Steven S. Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor. Br J Pharmacol. 2022;179(4):659–676. doi:10.1111/bph.15462
   PubMed Web of Science ®Google Scholar
• Buse JB, Bain SC, Mann JFE, et al. Cardiovascular risk reduction with liraglutide: an exploratory mediation analysis of the LEADER trial. Diabetes Care. 2020;43(7):1546–1552. doi:10.2337/dc19-2251
   PubMed Web of Science ®Google Scholar
• Rosen P, Osmers A. Oxidative stress in young Zucker rats with impaired glucose tolerance is diminished by acarbose. Horm Metab Res. 2006;38(9):575–586. doi:10.1055/s-2006-950397
   PubMed Web of Science ®Google Scholar
• Yang H, Song Y, Liang YN, Li R. Quercetin treatment improves renal function and protects the kidney in a rat model of adenine-induced chronic kidney disease. Med Sci Monit. 2018;24:4760–4766. doi:10.12659/MSM.909259
   PubMed Web of Science ®Google Scholar
• Huang DD, Shi G, Jiang Y, Yao C, Zhu C. A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomed Pharmacother. 2020;125:109767. doi:10.1016/j.biopha.2019.109767
   PubMed Web of Science ®Google Scholar
• García-Martínez BI, Ruiz-Ramos M, Pedraza-Chaverri J, Santiago-Osorio E, Mendoza-Núñez VM. Hypoglycemic effect of resveratrol: a systematic review and meta-analysis. Antioxidants. 2021;10(1):69. doi:10.3390/antiox10010069
   Web of Science ®Google Scholar
• Kukida M, Mogi M, Kan-No H, et al. AT2 receptor stimulation inhibits phosphate-induced vascular calcification. Kidney Int. 2019;95(1):138–148. doi:10.1016/j.kint.2018.07.028
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, André-Grégoire G, Nguyen Dinh Cat A, et al. Benefit of mineralocorticoid receptor antagonism in AKI: role of vascular smooth muscle rac1. J Am Soc Nephrol. 2017;28(4):1216–1226. doi:10.1681/ASN.2016040477
   PubMed Web of Science ®Google Scholar
• Schantl AE, Ivarsson ME, Leroux J-C. Investigational pharmacological treatments for vascular calcification. Adv Ther. 2019;2(1):1800094. doi:10.1002/adtp.201800094
   Google Scholar
• Yang YZ, Liu ZH, Wang SC, et al. Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs. Eur J Pharmacol. 2020;883:173314. doi:10.1016/j.ejphar.2020.173314
   PubMed Web of Science ®Google Scholar
• Zu Y, Lu X, Song J, Yu L, Li H, Wang S. Cinacalcet treatment significantly improves all-cause and cardiovascular survival in dialysis patients: results from a meta-analysis. Kidney Blood Press Res. 2019;44(6):1327–1338. doi:10.1159/000504139
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Caluwé R, Pyfferoen L, et al. Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the valkyrie study. J Am Soc Nephrol. 2020;31(1):186–196. doi:10.1681/asn.2019060579
   PubMed Web of Science ®Google Scholar
• Haroon SW, Tai BC, Ling LH, et al. Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): a study protocol for a randomized controlled trial. Medicine. 2020;99(36):e21906. doi:10.1097/md.0000000000021906
   PubMed Web of Science ®Google Scholar
• Anis KH, Pober D, Rosas SE. Vitamin D analogues and coronary calcification in CKD Stages 3 and 4: a randomized controlled trial of calcitriol versus paricalcitol. Kidn Med. 2020;2(4):450–458. doi:10.1016/j.xkme.2020.05.009
   PubMedGoogle Scholar
• Perelló J, Ferrer MD, Del Mar Pérez M, et al. Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis. Br J Pharmacol. 2020;177(19):4400–4415. doi:10.1111/bph.15163
   PubMed Web of Science ®Google Scholar
• Grases F, Sanchis P, Perello J, et al. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front Biosci. 2006;11:136–142. doi:10.2741/1786
   PubMed Web of Science ®Google Scholar
• Doran AC, Terry JG, Carr JJ, Linton MF. Statins and atherosclerotic lesion microcalcification: a new mechanism for plaque stability? Arterioscler Thromb Vasc Biol Apr. 2021;41(4):1306–1308. doi:10.1161/atvbaha.121.315949
   PubMed Web of Science ®Google Scholar
• Zhelyazkova-Savova MD, Yotov YT, Nikolova MN, et al. Statins, vascular calcification, and vitamin K-dependent proteins: is there a relation? Kaohs J Med Sci. 2021;37(7):624–631. doi:10.1002/kjm2.12373
   Google Scholar